Dr. Burzynski, MD, PhD, is a biochemist practicing in Texas who developed (using his own money) a nontoxic gene-targeted cancer therapy called antineoplastons. It has been shown to effectively help cure some of the most “incurable” forms of terminal cancer.

Dr. Burzynski had tried to get the FDA to review and approve antineoplastons since 1977, to no avail. To make sure he would not get into trouble for using the experimental therapy in his practice, his legal team confirmed that he was acting within the law and could use antineoplastons in his own practice “to meet the immediate needs of patients.” But in the 1980s the Texas Medical Board (TMB) charged him with breaking a law that didn’t actually exist and tried to revoke his medical license. Numerous investigations later—including an appearance before the Texas Supreme Court—found no violation of any law or standard of care. The TMB came up empty-handed.

In June of this year, the FDA, the pharmaceutical industry, and the National Cancer Institute all knew how promising Dr. Burzynski’s therapy was proving to be. Standard cancer treatment is based on very expensive machines and very expensive toxic drugs. There is an enormous amount of money to be made in this paradigm, and Dr. Burzynski’s work single-handedly threatened to overturn much of it. On the other hand, this treatment showed such promise that they wanted to get their hands on it themselves.

So first they tried to copy his invention using a single non-patented ingredient, and when that failed, they tried to steal his patents out from under him. However, they knew they couldn’t use the stolen patents so long as he had the ability to defend his rights. So the government spent over $60 million to prosecute him on 75 counts of violating federal law, hoping to tuck him away in jail for the rest of his life.

Now the Texas Medical Board is back. The TMB is making yet another attempt to revoke Dr. Burzynski’s medical license which, if successful, would result in the closure of his clinic, the abandonment of all his patients, and would squelch any possibility of antineoplastons gaining FDA-approval.

The Texas Medical Board v. Stanislaw Burzynski trial will begin on April 11, 2012. Gov. Rick Perry appointed a number of members of the TMB, including its heads, as well as the House Committee on Public Health and the Senate Committee on Health and Human Services, which oversee the TMB. This is about our right as citizens to choose our own cancer treatment—and not allow decades of important gene-targeted cancer research be flushed down the drain in the name of protecting the profits of an industry that doesn’t want Burzynski to survive. Please take action today!